Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:3
  • full-text downloads in 30 days:1
article: 1 from 6  
Back back to result list
Srpski arhiv za celokupno lekarstvo
2019, vol. 147, iss. 7-8, pp. 410-415
article language: English
document type: Original Paper
published on: 15/08/2019
doi: 10.2298/SARH180510051G
Initial respiratory specimen bacteriology and isolates susceptibility to antimicrobials in promptly intubated chronic obstructive pulmonary disease adults: Single-center two-year experience
University of Belgrade, Faculty of Medicine, Clinical Center 'Zemun'



Hormonal regulation of expression and activity of the nitric oxide synthase and sodium-potassium pump in experimental models of insulin resistance, diabetes and cardiovascular disorders (MESTD - 173033)


Introduction/Objective Chronic obstructive pulmonary disease (COPD) exacerbation is mostly triggered by infectious agents and seriously compromises the patient's quality of life and predicts a poor outcome of the disease as well. If the signs of the probable bacterial cause of COPD exacerbation are presented in an intubated patient, initial antimicrobial management must be launched. Depending on the results of the respiratory system sample cultures, the initial antimicrobials can be changed or continued. The objective of this study is to present in-hospital suggestions regarding the use of the initial antimicrobial management of urgently intubated COPD adults with the probable bacterial cause of exacerbations, considering the source of bacterial acquisition (i.e. facilityor community-acquired bacteria). Methods The cross-sectional study covered 51 patients urgently intubated on admission to the medical Intensive Care Unit of the Zemun Clinical Hospital Center during 2015/2016. The patients were divided into two groups: community-acquired (n = 26) and facility-acquired infection group (n = 25). The respiratory system samples were processed in the Microbiology Laboratory. Results Acinetobacter and Pseudomonas spp. were the most frequently isolated bacteria in both groups, followed by Staphylococcus aureus and Klebsiella spp. as the third most frequent bacteria in the communityand facility-acquired group, respectively. The parallel use of tigecycline and aminoglycosides proved to cover a sensitive microbial spectrum in 52% of examinees of the community-acquired and 32% of examinees of the facility-acquired group. Conclusion The present study suggests the initial management of intubated adults with probable bacterial infection-induced COPD exacerbation by the parallel use of tigecycline and aminoglycosides.



Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D.A., Barer, M.R., Johnston, S.L., Pavord, I.D., Brightling, C.E. (2012) Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine, 186(1): 48-55
Berre, L.R., Nguyen, S., Nowak, E., Kipnis, E., Pierre, M., Ader, F., et al. (2008) Quorum-sensing activity, and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect, 14(4): 337-380
Boixeda, R., Rabella, N., Sauca, G., Delgado, M., Martínez-Costa, X., Mauri, M., Vicente, V., Palomera, E., Serra-Pratt, M., Capdevila, J.A. (2012) Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study). International Journal of Chronic Obstructive Pulmonary Disease, 7: 327-327
Bott, J., Carroll, M.P., Conway, J.H., Keilty, S.E.J., Ward, E.M., Brown, A.M., Paul, E.A., Elliott, M.W., Godfrey, R.C., Wedzicha, J.A., Moxham, J. (1993) Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet, 341(8860): 1555-1557
Chambers, H.F., Eliopoulos, G.M., Gilbert, D.N., Pavia, A.T., Saag, M.S. (2016) The Sanford Guide to antimicrobial therapy 2016. Sperryville: Antimicrobial therapy, 46th ed, p. 110, 118
Chandra, D., Stamm, J.A., Taylor, B., Ramos, R.M., Satterwhite, L., Krishnan, J.A., Mannino, D., Sciurba, F.C., Holguín, F. (2012) Outcomes of Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the United States, 1998-2008. American Journal of Respiratory and Critical Care Medicine, 185(2): 152-159
Grochowalska, A., Kozioł-Montewka, M., Sobieszczańska, A. (2017) Analysis of Acinetobacter baumannii resistance patterns in patients with chronic obstructive pulmonary disease (COPD) in terms of choice of effective empiric antibiotic therapy. Annals of Agricultural and Environmental Medicine, 24(2): 307-311
Horan, T.C., Andrus, M., Dudeck, M.A. (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control, 36(5): 309-332
Johns Hopkins Hospital Antibiotic Guidelines 2015-2016.
Kuwal, A., Joshi, V., Dutt, N., Singh, S., Agarwal, K.C., Purohit, G. (2018) A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal, 19(1): 19-27
Lightowler, J.V., Wedzicha, J.A., Elliott, M.W., Ram, F.S. (2003) Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ, 326(7382): 185-185
Mahon, C.R., Lehman, D.C., Manuselis, G. (2014) Textbook of Diagnostic Microbiology. Philadelphia: Saunders Elsevier, 5th ed
Nakou, A., Papaparaskevas, J., Diamantea, F., Skarmoutsou, N., Polychronopoulos, V., Tsakris, A. (2014) A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. Future Microbiology, 9(11): 1251-1260
Papi, A., Bellettato, C.M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L.M., Johnston, S.L. (2006) Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. American Journal of Respiratory and Critical Care Medicine, 173(10): 1114-1121
Park, D.R. (2005) The Microbiology of ventilator-associated pneumonia. Respir Care, 50(6): 742-63
Plant, P.K., Owen, J.L., Elliott, M.W. (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: A multicentre randomised controlled trial. Lancet, 355(9219): 1931-1935
Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K. (2005) Pharmacology. Edinburgh: Churchill Livingstone, 5th ed, 635-52
Rossi, F., Girardello, R., Cury, A.P., di Gioia, T.S.R., de Almeida, J.N., Duarte, A.J.D.S. (2017) Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years. Brazilian Journal of Infectious Diseases, 21(1): 98-101
Sands, K.M., Wilson, M.J., Lewis, M.A.O., Wise, M.P., Palmer, N., Hayes, A.J., Barnes, R.A., Williams, D.W. (2017) Respiratory pathogen colonization of dental plaque, the lower airways, and endotracheal tube biofilms during mechanical ventilation. Journal of Critical Care, 37: 30-37
Shete, V.B., Ghadage, D.P., Muley, V.A., Bhore, A.V. (2010) Multi-drug resistant Acinetobacter ventilator-associated pneumonia. Lung India, 27(4): 217-237
Tripathi, P.C., Agrawal, G.N., Gajbhiye, S.R. (2014) Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug. Advanced Biomedical Research, 3(1): 13-13
van Saene, H.K.F., Damjanovic, V., Murray, A.E., de la Cal, M.A. (1996) How to classify infections in intensive care units-the carrier state: A criterion whose time has come?. Journal of Hospital Infection, 33(1): 1-12
Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Anzueto, A., Barnes, P.J., Bourbeau, J. (2017) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Eur Respir J, 49: 1700214-1700214
Wedzicha, J.A., Seemungal, T.A.R. (2007) COPD exacerbations: Defining their cause and prevention. Lancet, 370(9589): 786-796
White, A.J., Gompertz, S., Stockley, R.A. (2003) Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax, 58(1): 73-80
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Ieven, M., Ortqvist, A., i dr. (2005) Guidelines for the management of adult lower respiratory tract infections. European Respiratory Journal, 26(6): 1138
Woodruff, P.G., Barr, G.R., Bleecker, E., Christenson, S.A., Couper, D., Curtis, J.L., Gouskova, N.A., Hansel, N.N., Hoffman, E.A., Kanner, R.E., Kleerup, E., Lazarus, S.C., Martinez, F.J. (2016) Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. New England Journal of Medicine, 374(19): 1811-1821
Zurek, J., Fedora, M. (2012) Classification of infections in intensive care units: A comparison of current definition of hospital-acquired infections and carrier state criterion. Iran J Med Sci, 37(2): 100-104